-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EPBIAT1OFWYzhdMWCTNlWJl8jNpDKMMpWY5DmtkZJcMzOBfAb71KG7Kg//XW1E+F pM20GtUpntLlQmJxkqdPqg== 0001225208-09-006372.txt : 20090305 0001225208-09-006372.hdr.sgml : 20090305 20090305170640 ACCESSION NUMBER: 0001225208-09-006372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090303 FILED AS OF DATE: 20090305 DATE AS OF CHANGE: 20090305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDREOTTI LAMBERTO CENTRAL INDEX KEY: 0001208099 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 09659544 BUSINESS ADDRESS: STREET 1: BRISTOL MYERS SQUIBB CO STREET 2: RT 206 & PROVINCELLNE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 MAIL ADDRESS: STREET 1: BRISTOL MYERS SQUIBB CO STREET 2: RT 206 & PROVIINCELLE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 doc4.xml X0303 4 2009-03-03 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001208099 ANDREOTTI LAMBERTO 345 PARK AVENUE NEW YORK NY 10154 1 1 Pres & Chief Operating Officer Executive Option (right to buy) 17.51 2009-03-03 4 A 0 368706 0 A 2019-03-02 Common Stock, $0.10 par value 368706 368706 D Restricted Stock Units 0 2009-03-03 4 A 0 31032 0 A Common Stock, $0.10 par value 31032 31032 D Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Each restricted stock unit converts into one share of common stock upon vesting. One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. /s/ Sonia Vora, Attorney-in-Fact 2009-03-05 -----END PRIVACY-ENHANCED MESSAGE-----